Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-blind randomized two-period crossover study of sublingual zolpidem for insomnia
2006-005711-10Phase 2Completed
- Sponsor
- Orexo AB
- Start
- Dec 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Ambien IR in Insomnia (2 arms), sponsored by Orexo AB. Primary endpoint: Latency to persistent Sleep (LPS). Started Dec 2006; status: completed.
02
Drugs
Ambien IR
03
Conditions
Insomnia
Beyond the preview
Go deeper on 2006-005711-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005711-10.